Balance Sheet - LENZ Therapeutics, Inc. (LENZ)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 292.35 | 209.03 | 65.79 | 264.94 | 18.31 | 19.82 | 0.01 |
| Accounts receivable, net | 2.43 | 0.00 | |||||
| Inventories | 2.94 | 0.00 | |||||
| Other current assets | -2.43 | 2.89 | 1.45 | 2.20 | 0.02 | 1.29 | |
| Total current assets | 292.35 | 211.92 | 67.24 | 46.64 | 18.32 | 21.10 | 0.01 |
| Total non-current assets | 13.53 | 3.39 | 3.13 | 0.31 | 0.01 | 1.46 | |
| Total assets | 305.88 | 215.30 | 70.38 | 46.95 | 18.34 | 22.56 | 0.01 |
| Total current liabilities | 21.19 | 10.41 | 18.51 | 9.50 | 1.25 | 32.05 | 2.22 |
| Total non-current liabilities | 0.35 | 0.81 | 144.57 | 61.62 | 31.30 | 0.32 | |
| Total liabilities | 21.54 | 11.22 | 163.09 | 71.12 | 32.55 | 32.36 | 2.22 |
| Total stockholders' equity | 284.34 | 204.08 | -92.71 | -24.17 | -14.21 | -9.80 | -2.22 |
| Common shares outstanding | 29 | 21 | 8 | 8 | 8 | 8 | 8 |
Show Quarterly Balance Sheet
Balance Sheet - LENZ Therapeutics, Inc. (LENZ)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 258.39 | 292.35 | 202.17 | 209.52 | 193.98 | 209.03 | 217.11 | 196.11 | 213.28 | 65.79 | 88.15 | 246.67 | 264.10 | 264.94 | 291.69 | 322.29 | 339.18 | 531.09 | 549.07 | 382.11 | 177.16 | 19.82 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 0.34 | 2.43 | 0.00 | ||||||||||||||||||||||
| Inventories | 3.50 | 2.94 | 0.95 | 0.00 | |||||||||||||||||||||
| Other current assets | 6.14 | -2.43 | 3.88 | 4.08 | 3.88 | 2.89 | 3.60 | 3.24 | 3.40 | 1.45 | 1.73 | 4.51 | 6.21 | 2.20 | 6.81 | 4.35 | 4.57 | 4.76 | 6.28 | 2.64 | 3.10 | 1.29 | |||
| Total current assets | 268.37 | 292.35 | 207.00 | 213.60 | 197.86 | 211.92 | 220.70 | 199.35 | 216.67 | 67.24 | 89.88 | 251.17 | 270.31 | 46.64 | 298.49 | 326.64 | 343.76 | 381.74 | 401.23 | 384.75 | 180.27 | 21.10 | |||
| Total non-current assets | 4.17 | 13.53 | 3.71 | 3.73 | 3.39 | 3.39 | 3.30 | 3.29 | 0.65 | 3.13 | 2.30 | 35.87 | 39.69 | 0.31 | 36.35 | 27.14 | 34.85 | 20.25 | 14.92 | 2.35 | 2.65 | 1.46 | |||
| Total assets | 272.54 | 305.88 | 210.70 | 217.33 | 201.25 | 215.30 | 224.01 | 202.64 | 217.32 | 70.38 | 92.18 | 287.04 | 310.00 | 46.95 | 334.85 | 353.79 | 378.61 | 401.99 | 416.15 | 387.11 | 182.91 | 22.56 | |||
| Total current liabilities | 25.81 | 21.19 | 16.32 | 10.40 | 8.57 | 10.41 | 7.71 | 8.58 | 18.89 | 18.51 | 16.85 | 12.27 | 14.34 | 9.50 | 13.52 | 12.07 | 12.77 | 12.14 | 11.27 | 7.86 | 6.39 | 32.05 | |||
| Total non-current liabilities | 0.24 | 0.35 | 0.46 | 0.57 | 0.67 | 0.81 | 1.02 | 1.14 | 0.27 | 144.57 | 144.90 | 50.63 | 19.43 | 61.62 | 4.87 | 3.26 | 4.54 | 4.54 | 4.75 | 0.06 | 0.06 | 0.32 | |||
| Total liabilities | 26.04 | 21.54 | 16.78 | 10.97 | 9.24 | 11.22 | 8.73 | 9.72 | 19.16 | 163.09 | 161.74 | 62.90 | 33.77 | 71.12 | 18.39 | 15.33 | 17.31 | 12.14 | 16.02 | 7.92 | 6.46 | 32.36 | |||
| Total stockholders' equity | 246.49 | 284.34 | 193.93 | 206.37 | 192.01 | 204.08 | 215.28 | 192.92 | 198.17 | -92.71 | -69.57 | 224.15 | 276.22 | -24.17 | 316.45 | 338.46 | 361.30 | 389.84 | 400.13 | 379.18 | 176.46 | -9.80 | |||
| Common shares outstanding | 31 | 31 | 29 | 28 | 28 | 27 | 27 | 26 | 5 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |